These Form 3 filings confirm the appointment of three new insiders but provide no ownership or transaction data. Monitor future Form 4 filings for any share acquisitions or sales by these individuals, which would signal their conviction level.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 10 $3.76entry
- T+1 · 6d ago −6.65%α −7.97% · $3.51
- T+5 · 11h ago −2.53%α −0.20% · $3.67
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Three new insiders, Paul J. Hastings, Aida Habtezion, and Thomas M. Soloway, filed initial statements of beneficial ownership (Form 3) for Azora Therapeutics, each reporting zero shares beneficially owned. The filings are routine administrative steps for new officers or directors, with no financial data or trading activity disclosed.
Key Facts
- Paul J. Hastings filed Form 3 on 2026-11-10, reporting 0 shares beneficially owned as of 2026-11-03.
- Aida Habtezion filed Form 3 on 2026-11-10, reporting 0 shares beneficially owned as of 2026-11-03.
- Thomas M. Soloway filed Form 3 on 2026-11-10, reporting 0 shares beneficially owned as of 2026-11-03.
- Each filing included a power of attorney appointing Matthew Gene Davidson and others as attorneys-in-fact for SEC filings.
- Azora Therapeutics has a market cap of $11M and a normal daily move of 9.3%.
Financial Impact
No financial impact; each insider reported zero beneficial ownership.
Risk Factors
- No ownership data disclosed; insiders may acquire shares later, creating potential dilution or signaling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (AZR), Batch item 1 | 0001213900-26-117772 |
| Document: 0001213900-26-117772-index-headers.html | 0001213900-26-117771 |
| Document: 0001213900-26-117772-index.html | 0001213900-26-117773 |
| Document: 0001213900-26-117772.txt | 0001213900-26-117772 |
| 3 Filing (AZR), Batch item 5 | 0001213900-26-117771 |
| Document: 0001213900-26-117771-index-headers.html | 0001213900-26-117772 |
| Document: 0001213900-26-117771-index.html | 0001213900-26-117772 |
| Document: 0001213900-26-117771.txt | 0001213900-26-117772 |
| 3 Filing (AZR), Batch item 9 | 0001213900-26-117773 |
| Document: 0001213900-26-117773-index-headers.html | 0001213900-26-117772 |
| Document: 0001213900-26-117773-index.html | 0001213900-26-117772 |
| Document: 0001213900-26-117773.txt | 0001213900-26-117772 |
Track record
5 reports on AZR
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today S-3 Bearish 6/10 Entry $3.81 Now $3.66 +3.81% settles Nov 24
- Nov 12, 20265d ago 8-K Neutral 4/10 Entry $4.09 Now $3.66 −10.39% settles Nov 20
- Nov 10, 20267d ago 3 Neutral 2/10 Viewing Entry $3.76 to $3.67 Now $3.66 −2.53% ▼ −2.53% −0.20% vs SPY
- Nov 9, 20268d ago 8-K Neutral 4/10 Entry $3.75 to $3.81 Now $3.66 −2.27% ▲ +1.60% +3.29% vs SPY
- Nov 3, 202614d ago SC 13G/A Bearish 4/10 Entry $4.15 to $3.76 Now $3.66 +11.69% ▲ +9.40% +8.81% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers